載入中
Azenta, Inc. is a global leader specializing in advanced solutions for the discovery, handling, and preservation of life science samples. The company's operations span across North America, Europe, Asia Pacific (including China), and other international markets. Its business is structured into two main reportable segments: Life Sciences Products and Life Sciences Services. The Life Sciences Products division supplies sophisticated automated systems for the cold storage of chemical compounds and biological specimens. This segment also provides crucial equipment for sample preparation and manipulation, along with various consumables and specialized instruments that empower customers to effectively manage samples throughout their entire research and development workflows. Conversely, the Life Sciences Services segment offers a comprehensive suite of programs for sample management, integrated cold chain logistics, cutting-edge informatics, and a range of sample-centric laboratory services. These offerings are vital for propelling scientific research and accelerating drug development. Key services include secure sample banking, advanced genomic sequencing, gene synthesis, laboratory processing, detailed laboratory analysis, biospecimen acquisition, and other essential support functions. Azenta caters to a diverse client base within the life sciences sector, encompassing pharmaceutical companies, biotechnology firms, biorepositories, and academic or private research institutions. Established in 1978, the company, originally known as Brooks Automation, Inc., officially became Azenta, Inc. in December 2021. Its corporate headquarters are located in Chelmsford, Massachusetts.
NASDAQHealthcareMedical - Instruments & Supplies
最新資料
US$37.72
+US$1.72 · +4.78%
前收盤價
US$37.72
+US$1.72 · +4.78%
盤中時間採用ET。市場資料可能有所延遲。
Azenta, Inc. is a global leader specializing in advanced solutions for the discovery, handling, and preservation of life science samples. The company's operations span across North America, Europe, Asia Pacific (including China), and other international markets. Its business is structured into two main reportable segments: Life Sciences Products and Life Sciences Services. The Life Sciences Products division supplies sophisticated automated systems for the cold storage of chemical compounds and biological specimens. This segment also provides crucial equipment for sample preparation and manipulation, along with various consumables and specialized instruments that empower customers to effectively manage samples throughout their entire research and development workflows. Conversely, the Life Sciences Services segment offers a comprehensive suite of programs for sample management, integrated cold chain logistics, cutting-edge informatics, and a range of sample-centric laboratory services. These offerings are vital for propelling scientific research and accelerating drug development. Key services include secure sample banking, advanced genomic sequencing, gene synthesis, laboratory processing, detailed laboratory analysis, biospecimen acquisition, and other essential support functions. Azenta caters to a diverse client base within the life sciences sector, encompassing pharmaceutical companies, biotechnology firms, biorepositories, and academic or private research institutions. Established in 1978, the company, originally known as Brooks Automation, Inc., officially became Azenta, Inc. in December 2021. Its corporate headquarters are located in Chelmsford, Massachusetts.
日內區間
目前US$37.72
52週區間
目前US$37.72
盤中時間採用ET。市場資料可能有所延遲。
GoAI 評分
持有
估值
47
合理估值
情緒
54
多空交錯
風險
55
風險偏高
動能
39
動能減弱
完整 GoAI 研究
繼續查看更深入的依據、催化因素和風險。
Azenta, Inc. is a global leader specializing in advanced solutions for the discovery, handling, and preservation of life science samples. The company's operations span across North America, Europe, Asia Pacific (including China), and other international markets. Its business is structured into two main reportable segments: Life Sciences Products and Life Sciences Services. The Life Sciences Products division supplies sophisticated automated systems for the cold storage of chemical compounds and biological specimens. This segment also provides crucial equipment for sample preparation and manipulation, along with various consumables and specialized instruments that empower customers to effectively manage samples throughout their entire research and development workflows. Conversely, the Life Sciences Services segment offers a comprehensive suite of programs for sample management, integrated cold chain logistics, cutting-edge informatics, and a range of sample-centric laboratory services. These offerings are vital for propelling scientific research and accelerating drug development. Key services include secure sample banking, advanced genomic sequencing, gene synthesis, laboratory processing, detailed laboratory analysis, biospecimen acquisition, and other essential support functions. Azenta caters to a diverse client base within the life sciences sector, encompassing pharmaceutical companies, biotechnology firms, biorepositories, and academic or private research institutions. Established in 1978, the company, originally known as Brooks Automation, Inc., officially became Azenta, Inc. in December 2021. Its corporate headquarters are located in Chelmsford, Massachusetts.
日內區間
目前US$37.72
52週區間
目前US$37.72
獲利能力占已公布營收的百分比。
營收
營業利益
淨利
| 項目（USD） | 2025會計年度 | 2024會計年度 | 2023會計年度 | 2022會計年度 | 2021會計年度 |
|---|---|---|---|---|---|
| 營收 | 5.94億 USD | 5.73億 USD | 6.65億 USD | 5.55億 USD | 5.14億 USD |
| 銷貨成本 | 3.24億 USD | 3.19億 USD | 4.32億 USD | 3.25億 USD | 2.99億 USD |
| 毛利 | 2.7億 USD | 2.55億 USD | 2.33億 USD | 2.31億 USD | 2.15億 USD |
| 研究與開發 | 3039萬 USD | 3152.4萬 USD | 3395.6萬 USD | 2754.2萬 USD | 2241.2萬 USD |
| 銷售、一般及管理費用 | 2.51億 USD | 2.53億 USD | 2.81億 USD | 2.27億 USD | 1.89億 USD |
| 營業費用 | 2.82億 USD | 2.85億 USD | 3.15億 USD | 2.55億 USD | 2.11億 USD |
| 利息收入 | 1877.9萬 USD | 3317.7萬 USD | 4373.5萬 USD | 2028.6萬 USD | 63.2萬 USD |
| 利息支出 | — | — | — | 458.9萬 USD | 203.7萬 USD |
| 折舊和攤銷 | 6120.9萬 USD | 9074.4萬 USD | 8558.4萬 USD | 5370.2萬 USD | 5687.2萬 USD |
| 營業利益 | −1126.8萬 USD | −2998.1萬 USD | −8219.8萬 USD | −2402.3萬 USD | 359.6萬 USD |
| 淨利 | −5576.3萬 USD | −1.65億 USD | −1425.7萬 USD | −4.29億 USD | 1.11億 USD |
公司資料更新於 2026年10月12日。
近期已公布業績
近期已公布業績
第三方分析師預期可能變動，並非 GoAI 建議。
平均目標
US$43.00
上漲空間 14.00%年度分割調整後的每股現金分配。
US$0.40
2021年（完整年度）0.0% 自從 2017
US$0.40
2,017
US$0.40
2,018
US$0.40
2,019
US$0.40
2,020
US$0.40
2,021
| 行動 | 除息日 | 詳情 | 記錄日期 | 付款日期 |
|---|---|---|---|---|
股息 | 2021年12月2日 | US$0.10Quarterly | 2021年12月3日 | 2021年12月23日 |
股息 | 2021年9月2日 | US$0.10Quarterly | 2021年9月3日 | 2021年9月24日 |
股息 | 2021年6月3日 | US$0.10Quarterly | 2021年6月4日 | 2021年6月25日 |
股息 | 2021年3月4日 | US$0.10Quarterly | 2021年3月5日 | 2021年3月26日 |
股息 | 2020年12月3日 | US$0.10Quarterly | 2020年12月4日 | 2020年12月17日 |
股息 | 2020年9月3日 | US$0.10Quarterly | 2020年9月4日 | 2020年9月25日 |
除息 2021年12月2日
US$0.10
Quarterly
2021年12月3日登記 · 支付日 2021年12月23日
除息 2021年9月2日
US$0.10
Quarterly
2021年9月3日登記 · 支付日 2021年9月24日
除息 2021年6月3日
US$0.10
Quarterly
2021年6月4日登記 · 支付日 2021年6月25日
除息 2021年3月4日
US$0.10
Quarterly
2021年3月5日登記 · 支付日 2021年3月26日
除息 2020年12月3日
US$0.10
Quarterly
2020年12月4日登記 · 支付日 2020年12月17日
除息 2020年9月3日
US$0.10
Quarterly
2020年9月4日登記 · 支付日 2020年9月25日
報告持有此股票曝險的交易所交易基金。
iShares Core S&P Small-Cap ETFIJR8474.14萬0.08%1031.91億 USD0.06%US$137.55+0.17%
Vanguard Morningstar Total Stock Market ETFVTI4315.42萬0.00%2.3兆 USD0.03%US$381.94+0.63%
iShares Russell 2000 ETFIWM3995.15萬0.05%787.4億 USD0.19%US$278.94+0.49%
Vanguard Morningstar Small-Cap ETFVB3114.85萬0.02%1853億 USD0.03%US$289.48+0.64%
Vanguard Morningstar Small-Cap Value ETFVBR1979.14萬0.03%682億 USD0.05%US$234.43+0.22%
Vanguard Extended Market ETFVXF1554.29萬0.02%954億 USD0.05%US$235+0.80%
U.S. Small Cap Value Portfolio ETF Class SharesDFSV1397.51萬0.05%268.09億 USD0.33%US$37.95-0.39%
State Street SPDR Portfolio S&P 600 Small Cap ETFSPSM1304.16萬0.08%158.4億 USD0.03%US$53.45+0.17%iShares Core S&P Small-Cap ETFIJRVanguard Morningstar Total Stock Market ETFVTIiShares Russell 2000 ETFIWMVanguard Morningstar Small-Cap ETFVBVanguard Morningstar Small-Cap Value ETFVBRVanguard Extended Market ETFVXFU.S. Small Cap Value Portfolio ETF Class SharesDFSVState Street SPDR Portfolio S&P 600 Small Cap ETFSPSMAI 生成內容及延遲市場資料僅供資訊與教育用途，不構成投資建議。
